Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The participants are being treated with Tumor Treating Fields (TTFields) for malignant
glioma, and this type of treatment may cause skin-related side effects. This study will test
whether using clindamycin and triamcinolone topical lotions can prevent skin-related side
effects of TTFields.